A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers.
Rheumatology and Therapy(2024)
Key words
Clinical trial,Fibrosis,Healthy volunteers,Monoclonal antibody,Phase 1,RO7303509,Systemic sclerosis,Transforming growth factor beta (TGFβ),TGFβ3
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined